Performance of a novel active fixation quadripolar left ventricular lead for cardiac resynchronization therapy: Attain Stability Quad Clinical Study results

• Published in: Journal of cardiovascular electrophysiology 2020-05, Vol.31 (5), p.1147-1154
• Main Authors: Jackson, Kevin P., Faerestrand, Svein, Philippon, Francois, Yee, Raymond, Kong, Melissa H., Kloppe, Axel, Bongiorni, Maria Grazia, Lee, Scott F., Canby, Robert C., Pouliot, Erika, Ginneken, Mireille M. E., Crossley, George H.
• Format: Article
• Language: English
• Subjects: active fixation; Aged; Aged, 80 and over; cardiac resynchronization therapy; Cardiac Resynchronization Therapy - adverse effects; Cardiac Resynchronization Therapy Devices; Equipment Design; Female; Heart; Heart Failure - diagnosis; Heart Failure - physiopathology; Heart Failure - therapy; Humans; lead dislodgement; LV lead; Male; Middle Aged; Prospective Studies; quadripolar lead; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ventricle; Ventricular Function, Left
• ISSN: 1045-3873; 1540-8167
• DOI: 10.1111/jce.14439

Introduction The Medtronic Attain Stability Quad lead is a quadripolar left ventricular (LV) lead with an active fixation helix assembly designed to fixate the lead within the coronary sinus and pace nonapical regions of the LV. The primary objective of this study was to determine the safety and effectiveness of this novel active fixation quadripolar LV lead. Methods Patients with standard indications for cardiac resynchronization therapy (CRT) were enrolled. All patients were followed at 3 and 6 months post‐implant and every 6 months thereafter until study closure. Pacing capture thresholds (PCTs) were measured at implant and each follow‐up and adverse events (AEs) were recorded upon occurrence. Results Of the 440 patients who underwent implant procedures, placement of the Attain Stability Quad lead was successful in 426 (96.8%). LV lead‐related complications occurred in 10 patients (2.3%), including LV lead dislodgement in three patients (0.7%). The percentage of patients with at least one LV pacing vector with a PCT ≤2.5 V at a 6‐month follow‐up was 96.3%. The LV lead was successfully fixated to the prespecified pacing location in 97.4% of cases. Conclusions This large, multinational study of the Attain Stability Quad lead demonstrated a high rate of implant success with a low complication rate. The active fixation mechanism allowed precise placement of the pacing electrodes at the desired target region with good PCTs and a very low dislodgement rate.